Evidence map›Paper›PMID 40434526›Full record

ArticleActa neuropathologica2025

Thalamic atrophy in multiple sclerosis is associated with tract disconnection and altered microglia.

Carla Rodriguez-Mogeda, Ismail Koubiyr, Stefanos E Prouskas, Margarita Georgallidou, Susanne M A van der Pol, Rosalia Franco Fernandez, Yvon Galis de Graaf, Ysbrand D van der Werf, Laura E Jonkman, Geert J Schenk and 5 more

Abstract read
In one paragraph

Article in Acta neuropathologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Carla Rodriguez-Mogeda *Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Ismail Koubiyr *MS Center Amsterdam, Amsterdam UMC Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Stefanos E ProuskasMS Center Amsterdam, Amsterdam UMC Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Margarita GeorgallidouAnatomy and Neurosciences, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Susanne M A van der PolMolecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Rosalia Franco FernandezMolecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Yvon Galis de GraafAnatomy and Neurosciences, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Ysbrand D van der WerfAnatomy and Neurosciences, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Laura E JonkmanAnatomy and Neurosciences, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Geert J SchenkMS Center Amsterdam, Amsterdam UMC Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Frederik BarkhofMS Center Amsterdam, Amsterdam UMC Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Hanneke E HulstAnatomy and Neurosciences, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Maarten E WitteMolecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Menno M Schoonheim *MS Center Amsterdam, Amsterdam UMC Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands. m.schoonheim@amsterdamumc.nl.
Helga E de Vries *Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.

Funding

Stichting MS Research 18-358fMSStichting MS Research 22-358fMSZonMw 09150172010056
6 · The paper itself

Abstract

Thalamic atrophy already occurs in the early stages of multiple sclerosis (MS) and continues progressively throughout the disease. Demyelination is one of the main pathological hallmarks of MS and yet, thalamic demyelination does not correlate well with thalamic atrophy. By combining post-mortem magnetic resonance imaging with immunohistochemistry of thalami from 13 control and 13 MS donors, we investigated the underlying pathological contributors of thalamic atrophy and pathology. We first assessed the volumes of four thalamic nuclei groups (anterior, lateral, medial and posterior). Then, diffusion weighted imaging was used to assess the microstructural integrity of white matter tracts connecting each thalamic nuclei group. In addition, we studied myelination, inflammation, neurodegeneration and microglial activation by immunohistochemistry. We uncovered that medial and posterior thalamic nuclei were more atrophic compared to the anterior and lateral nuclei. Bilateral posterior nuclei and the right medial and anterior nuclei showed reduced fractional anisotropy in connected white matter tracks. We further show that microglial cells in the mediodorsal nuclei have an increased density and morphological complexity in MS compared to control donors. Microglia show signs of phagocytosis of pre-synapses, although we did not observe an overall synaptic loss in the thalamus of MS donors. These microglial changes within mediodorsal nuclei correlated with lower medial thalamic volume. Taken together, this study provides evidence that thalamic (subnuclear) atrophy relates tostructural thalamic network disconnection and within-thalamic microglial changes, but not thalamic demyelination. These findings could impact future treatment strategies aimed at thalamic neuroprotection.

Indexed as

MicrogliaMultiple SclerosisThalamusAdultAgedAtrophyFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeural PathwaysWhite MatterAtrophyMicrogliaMultiple sclerosisPost-mortemThalamus

Identifiers

PMID40434526
PMCPMC12119693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.